Manichem Limited 06038719 true 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is that of a retail pharmacy and the sale of wholesale pharmaceutical products. On 1 February 2019 the trade, assets and liabilities were transferred to Enimed Limited, its parent company. The company became dormant at that point. Digita Accounts Production Advanced 6.30.9574.0 true Vikash Patel Krishma Patel Niral Patel Viresh Patel true true 06038719 2022-04-01 2023-03-31 06038719 2023-03-31 06038719 bus:OrdinaryShareClass1 2023-03-31 06038719 core:RetainedEarningsAccumulatedLosses 2023-03-31 06038719 core:ShareCapital 2023-03-31 06038719 bus:FRS102 2022-04-01 2023-03-31 06038719 bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 06038719 bus:FullAccounts 2022-04-01 2023-03-31 06038719 bus:RegisteredOffice 2022-04-01 2023-03-31 06038719 bus:Director1 2022-04-01 2023-03-31 06038719 bus:Director2 2022-04-01 2023-03-31 06038719 bus:Director3 2022-04-01 2023-03-31 06038719 bus:Director4 2022-04-01 2023-03-31 06038719 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 06038719 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 06038719 1 2022-04-01 2023-03-31 06038719 countries:EnglandWales 2022-04-01 2023-03-31 06038719 2022-03-31 06038719 bus:OrdinaryShareClass1 2022-03-31 06038719 core:RetainedEarningsAccumulatedLosses 2022-03-31 06038719 core:ShareCapital 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06038719

Manichem Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

Manichem Limited

Profit and Loss Account for the Year Ended 31 March 2023

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Manichem Limited

(Registration number: 06038719)
Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Capital and reserves

 

Called up share capital

3

100

100

Retained earnings

(100)

(100)

Shareholders' funds/(deficit)

 

-

-

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 12 April 2023 and signed on its behalf by:
 


Vikash Patel
Director

 

Manichem Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
109-111 Field End Road
Pinner
HA5 1QG
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Summary of disclosure exemptions

Manichem Limited meets the definition of a qualifying entity under FRS102 and has therefore taken advantage of the disclosure exemptions availability to it in respect of its financial statements. Exemption has been taken in relation to financial instruments, presentation of a statement of cash flows and key management personnel compensation.

Name of parent of group

These financial statements are consolidated in the financial statements of Enimed Limited.

The financial statements of Enimed Limited may be obtained from the company's registered office.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies..

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Manichem Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

3

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

         

4

Parent and ultimate parent undertaking

The most senior parent entity producing publicaly available consolidated financial statements, including the company, is Enimed Limited. These consolidated financial statements are available upon request from 109-111 Field End Road, Pinner, HA5 1 QG.

 The company's immediate parent is Merrygood Limited, incorporated in England and Wales.

 The ultimate parent is Enimed Limited, incorporated in England and Wales.